1 / 11

The Factor II ( Prothrombin ) G20210A Detection and Genotyping

Learn about the Factor II G20210A mutation, the most common inherited coagulation disorder in the U.S. Discover its inheritance pattern, prevalence, and associated risks. Find out about the Factor II G20210A assay, including extraction methods, amplification, detection, and genotyping procedures using the MagNA Pure LC DNA Isolation Kit and LightCycler 2.0 instrument by Roche Diagnostics.

ortizl
Download Presentation

The Factor II ( Prothrombin ) G20210A Detection and Genotyping

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Factor II (Prothrombin) G20210A Detection and Genotyping August 2nd, 2010 By Christi Le

  2. Factor II (Prothrombin) G20210A • Most common inherited coagulation disorder in U.S. • Autosomal dominant inheritance. • Inherited condition • Third most common cardiovascular disease. • Single point mutation (G to A at position 20210) • 2-5% in Caucasians • 0.3% in African Americans • Heterozygous= 2-4 fold increased risk of thrombosis. • Homozygous= 80 fold increased risk of thrombosis. • Treatment= clinical circumstances and may include anticoagulation therapy.

  3. Factor II (Prothrombin) G20210A Assay • Extraction- MagNA Pure LC DNA Isolation Kit I and instrument (Roche Diagnostics) • Amplification/ Detection/ Genotyping= factor II (Prothrombin G20210A Kit and LightCycler 2.0 instrument. (Roche Diagnostics)

  4. Extraction: • Specimen- EDTA whole blood (50 mL whole blood= 100 mL purification product) • MagNA Pure LC Total Nucleic Acid Isolation Kit – large volume 192 Isolation; sample cartridge, elution cartridge, disposable pipette tip tray assembly, and processing cartridge. • MagNA Pure LC Instrument- automated method DNA I Blood Cell Fast.

  5. Real time PCR (or Amplification or detection) • Target- 165bp fragment of Factor II gene • Factor II (Prothrombin) G20210A kit- master mix reagents primers and probes) • LightCycler 2.0 instrument- 32 cycles in 30 minutes. • There are 3 cycle temperature- denaturation 95 degrees Celsius, annealing 60 degrees Celsius, and elongation 72 degrees Celsius. • Thermal cycler: heat/ambient air cycle. • Reaction tube: 20 mL glass capillary tube.

  6. Summary: • Erroneous results: -patient sample with elevated WBC -false positive (3 rare mutations piece same mutation probe) • Limitations: high conc. of heparin might interfere with the PCR/instruments and technical process. • Overall, it is a very clever system and also an important role in molecular diagnostic clinical lab

More Related